Skip to content
healthcare.dev
Get a free key

NASAL DECONGESTANT PE 10mg

NDC 73581-204, PHENYLPHRINE HCL, tablet, from YYBA CORP.

Product NDC
73581-204
Status
Listed
Labeler
YYBA CORP
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73581-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENYLEPHRINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
73581-204-0273581020402200 TABLET in 1 BOTTLE (73581-204-02)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 73581-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73581-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73581-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.